Our Research Publications
Updated November 2023
Pagination
- Previous page
- Page 43
- Next page
Title Sort descending | Authors | Year | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Using blood donors and solid organ transplant donors and recipients to estimate the seroprevalence of cytomegalovirus and Epstein–Barr virus in Canada: A cross-sectional study | Mabilangan C, Burton C, O'Brien S, Plitt S, Eurich DT, Preiksaitis J | 2020 | JAMMI | View Using blood donors and solid organ transplant donors and recipients to estimate the seroprevalence of cytomegalovirus and Epstein–Barr virus in Canada: A cross-sectional study | Researchers | Clinical research |
Using Blood Wisely One Year Later – Ontario Hospitals Stepping Up to the Challenge | Day D, Lin Y | 2021 | Ontario Regional Blood Coordinating Network September 2021 Newsletter | View Using Blood Wisely One Year Later – Ontario Hospitals Stepping Up to the Challenge | Health care providers | Benchmarking and standard setting |
Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review | Yu JK, Iorio A, Edginton AN, Wapps co?investigators | 2019 | Res Pract Thromb Haemost | View Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review | Researchers | Clinical research |
Using pharmacokinetics to individualize hemophilia therapy | Iorio A | 2017 | Hematology Am Soc Hematol Educ Program | View Using pharmacokinetics to individualize hemophilia therapy | Health care providers | Clinical research |
Using population-wide administrative and laboratory data to estimate type- and subtype-specific influenza vaccine effectiveness: a surveillance protocol | Scott AN, Buchan SA, Kwong JC, Drews SJ, Simmonds KA, Svenson LW | 2019 | BMJ Open | View Using population-wide administrative and laboratory data to estimate type- and subtype-specific influenza vaccine effectiveness: a surveillance protocol | Researchers | Clinical research |
Using Raman spectroscopy to assess hemoglobin oxygenation in red blood cell concentrate: an objective proxy for morphological index to gauge the quality of stored blood? | Atkins CG, Schulze HG, Chen D, Devine DV, Blades MW, Turner RF | 2017 | Analyst | View Using Raman spectroscopy to assess hemoglobin oxygenation in red blood cell concentrate: an objective proxy for morphological index to gauge the quality of stored blood? | Researchers | New or improved product or process |
Using simulation for strategic blood supply chain design in the Canadian prairies | Blake J, McTaggart K | 2016 | Proceedings of the 6th International Conference on SIMULTECH | View Using simulation for strategic blood supply chain design in the Canadian prairies | Blood operators | New or improved product or process |
Using simulation to evaluate a blood supply network in the Canadian maritime provinces | Blake J, Hardy M | 2013 | J Enterp Inf Manag | View Using simulation to evaluate a blood supply network in the Canadian maritime provinces | Researchers | New or improved product or process |
Using the K/BxN mouse model of endogenous, chronic, rheumatoid arthritis for the evaluation of potential immunoglobulin-based therapeutic agents, including IVIg and Fc-?TP-L309C, a recombinant IgG1 Fc hexamer | Lewis BJB, Ville J, Blacquiere M, Cen S, Spirig R, Zuercher AW, Käsermann F, Branch DR | 2019 | BMC Immunol | View Using the K/BxN mouse model of endogenous, chronic, rheumatoid arthritis for the evaluation of potential immunoglobulin-based therapeutic agents, including IVIg and Fc-?TP-L309C, a recombinant IgG1 Fc hexamer | Researchers | Basic research |
Using umbilical cord blood for regenerative therapy: Proof or promise? | Allan DS | 2020 | Stem Cells | View Using umbilical cord blood for regenerative therapy: Proof or promise? | Researchers | Clinical research |
Utilisation des produits sanguins CMV négatifs | Ryan J | 2017 | Blood.ca website | View Utilisation des produits sanguins CMV négatifs | Health care providers | Benchmarking and standard setting |
Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk-stratify patients for alloimmunisation risk | Shih AW, Yan MTS, Elahie AL, Barty RL, Liu Y, Berardi P, Azzam M, Siddiqui R, Parvizian MK, Mcdougall T, Heddle NM, Al-Habsi KS, Goldman M, Cote J, Athale U, Verhovsek MM | 2020 | Transfus Med | View Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk-stratify patients for alloimmunisation risk | Health care providers | Clinical research |
Utility of cross-matched platelet transfusions in patients with hypoproliferative thrombocytopenia: a systematic review | Vassallo RR, Fung M, Rebulla P, Duquesnoy R, Saw CL, Slichter SJ, Tanael S, Shehata N, International Collaboration for Guideline Development Implementation Evaluation for Transfusion Therapies Collaborators | 2013 | Transfusion | View Utility of cross-matched platelet transfusions in patients with hypoproliferative thrombocytopenia: a systematic review | Researchers | Clinical research |
Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders | Olasupo OO, Haddix C, Nakar C, Maahs J, Greist A, Ghafoor A, Donfield SM, Iorio A, Shapiro AD | 2022 | Eur J Haematol | View Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders | Health care providers | Benchmarking and standard setting |
Utilization of frozen plasma in Ontario: a province wide audit reveals a high rate of inappropriate transfusions | Tinmouth A, Thompson T, Arnold DM, Callum JL, Gagliardi K, Lauzon D, Owens W, Pinkerton P | 2013 | Transfusion | View Utilization of frozen plasma in Ontario: a province wide audit reveals a high rate of inappropriate transfusions | Health care providers | Benchmarking and standard setting |
Utilization of frozen plasma, cryoprecipitate, and recombinant factor VIIa for children with hemostatic impairments: An audit of transfusion appropriateness | Lieberman L, Lin Y, Cserti-Gazdewich C, Yi QL, Pendergrast J, Lau W, Callum J | 2018 | Pediatr Blood Cancer | View Utilization of frozen plasma, cryoprecipitate, and recombinant factor VIIa for children with hemostatic impairments: An audit of transfusion appropriateness | Health care providers | Clinical research |
Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses | Lin Y-CJ, Evans DH, Robbins NF, Orjuela G, Hu Q, Samson R, Abe KT, Rathod B, Colwill K, Gingras A-C, Tuite A, Yi Q-L, O’Brien SF, Drews SJ | 2022 | Microbiol Spectr | View Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses | Health care providers | Benchmarking and standard setting |
Vaccine Effectiveness Against Lineage-matched and -mismatched Influenza B Viruses Across 8 Seasons in Canada, 2010–2011 to 2017–2018 | Chambers C, Hickman R, Sabaiduc S, Chan T, Jassem A, Rose C, Krajden M, Skowronski DM, Petric M, De Serres G, Martineau C, Charest H, Winter A-L, Gubbay JB, Dickinson JA, Fonseca K, Drews SJ, Bastien N, Li Y | 2018 | Clin Infect Dis | View Vaccine Effectiveness Against Lineage-matched and -mismatched Influenza B Viruses Across 8 Seasons in Canada, 2010–2011 to 2017–2018 | Researchers | Clinical research |
Vaccine-induced immune thrombotic thrombocytopenia | Klok FA, Pai M, Huisman MV, Makris M | 2022 | Lancet Haematol | View Vaccine-induced immune thrombotic thrombocytopenia | Researchers | Clinical research |
Vaccine-induced immune thrombotic thrombocytopenia (VITT) - update on diagnosis and management considering different resources: Response to Comment from Yamada et al | Greinacher A, Langer F, Makris M, Pai M, Pavord S, Tran H, Warkentin TE | 2022 | J Thromb Haemost | View Vaccine-induced immune thrombotic thrombocytopenia (VITT) - update on diagnosis and management considering different resources: Response to Comment from Yamada et al | Health care providers | Clinical research |
Vaccine-induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources | Greinacher A, Langer F, Makris M, Pai M, Pavord S, Tran H, Warkentin TE | 2022 | J Thromb Haemost | View Vaccine-induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources | Health care providers | Clinical research |
Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil | Mouta Nunes de Oliveira P, Mendes-de-Almeida DP, Bertollo Gomes Porto V, Crespo Cordeiro C, Vitiello Teixeira G, Saraiva Pedro R, Roberto Gomes Takey P, Kegele Lignani L, Reis Xavier J, Cardoso Doria da Gama V, Amorim Filho L, Emoingt Furtado B, Santa Maria A, Dahrug Barros T, Neves Waite Freitas L, Dos Santos Pereira T, Lima Abreu D, Bernardes Ramos M, Gabe C, Arnold D, William Smith J, Nazy I, Lourdes de Sousa Maia M | 2022 | Vaccine | View Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil | Health care providers | Clinical research |
Vaccine-induced immune thrombotic thrombocytopenia presenting with normal platelet count | Page D, Zhu N, Sawler D, Sun HW, Turley E, Pai M, Wu C | 2021 | Res Pract Thromb Haemost | View Vaccine-induced immune thrombotic thrombocytopenia presenting with normal platelet count | Researchers | Clinical research |
Vaccine-induced immune thrombotic thrombocytopenia: Updates in pathobiology and diagnosis | Jevtic SD, Arnold DM, Modi D, Ivetic N, Bissola AL, Nazy I | 2022 | Front Cardiovasc Med | View Vaccine-induced immune thrombotic thrombocytopenia: Updates in pathobiology and diagnosis | Health care providers | Clinical research |
Validation and implementation of a new hemoglobinometer for donor screening at Canadian Blood Services | Goldman M, Uzicanin S, Yi QL, Acker JP, Ramirez-Arcos S | 2012 | Transfusion | View Validation and implementation of a new hemoglobinometer for donor screening at Canadian Blood Services | Blood operators | New or improved product or process |
Validation of a flow-cytometry-based red blood cell antigen phenotyping method | Liwski R, Clarke G, Cheng C, Abidi SSR, Abidi SR, Quinn JG | 2023 | Vox Sang | View Validation of a flow-cytometry-based red blood cell antigen phenotyping method | Health care providers | New or improved product or process |
Validation of administrative database codes for acute kidney injury in kidney transplant recipients | Molnar AO, van Walraven C, McArthur E, Fergusson D, Garg AX, Knoll G | 2016 | Can J Kidney Health Dis | View Validation of administrative database codes for acute kidney injury in kidney transplant recipients | Regulators | New or improved product or process |
Validation of sterility testing of cord blood: Challenges and results | Ramirez-Arcos S, Kou Y, Yang L, Perkins H, Taha M, Halpenny M, Elmoazzen H | 2015 | Transfusion | View Validation of sterility testing of cord blood: Challenges and results | Blood operators | New or improved product or process |
Value of MMA crossmatch? | Tong TN, Cserti-Gazdewich CM, Branch DR | 2016 | Transfus Med | View Value of MMA crossmatch? | Researchers | Basic research |
Vancomycin | Arnold DM | 2015 | Reactions Weekly | View Vancomycin | Health care providers | Other |
Variations in hemoglobin measurement and eligibility criteria across blood donation services are associated with differing low-hemoglobin deferral rates: a BEST Collaborative study | Zalpuri S, Romeijn B, Allara E, Goldman M, Kamel H, Gorlin J, Vassallo R, Grégoire Y, Goto N, Flanagan P, Speedy J, Buser A, Kutner JM, Magnussen K, Castrén J, Culler L, Sussmann H, Prinsze FJ, Belanger K, Compernolle V, Tiberghien P, Cardenas JM, Gandhi MJ, West KA, Lee CK, James S, Wells D, Sutor LJ, Wendel S, Coleman M, Seltsam A, Roden K, Steele WR, Bohonek M, Alcantara R, Di Angelantonio E, van den Hurk K, BEST Collaborative | 2020 | Transfusion | View Variations in hemoglobin measurement and eligibility criteria across blood donation services are associated with differing low-hemoglobin deferral rates: a BEST Collaborative study | Health care providers | Clinical research |
Variations in RBC and frozen plasma utilization rates across 62 Ontario community hospitals | Qiang JK, Thompson T, Callum J, Pinkerton P, Lin Y | 2019 | Transfusion | View Variations in RBC and frozen plasma utilization rates across 62 Ontario community hospitals | Health care providers | Clinical research |
Vascular endothelial dysfunction in beta-thalassemia occurs despite increased eNOS expression and preserved vascular smooth muscle cell reactivity to NO | Stoyanova E, Trudel M, Felfly H, Lemsaddek W, Garcia D, Cloutier G | 2012 | PLoS One | View Vascular endothelial dysfunction in beta-thalassemia occurs despite increased eNOS expression and preserved vascular smooth muscle cell reactivity to NO | Researchers | Basic research |
Vein to Vein: A Summary of the Blood System in Canada | Chargé S | 2019 | Clinical Guide to Transfusion | View Vein to Vein: A Summary of the Blood System in Canada | Health care providers | Benchmarking and standard setting |
Venous limb gangrene and pulseless electrical activity (PEA) cardiac arrest during management of deep-vein thrombosis and progressive limb ischemic necrosis following vascular surgery | Avram AT, Blostein MD, Hirsch AM, Warkentin TE | 2020 | Am J Hematol | View Venous limb gangrene and pulseless electrical activity (PEA) cardiac arrest during management of deep-vein thrombosis and progressive limb ischemic necrosis following vascular surgery | Health care providers | Clinical research |
Venous Thromboembolism and Mild Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination | Gabarin N, Patterson S, Pai M, Afzaal T, Nazy I, Sheppard JI, Arnold DM, Warkentin TE | 2021 | Thromb Haemost | View Venous Thromboembolism and Mild Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination | Health care providers | Clinical research |
Venous thromboembolism in pediatric inflammatory bowel disease: an 11-year population-based nested case-control study in Canada | Ding Z, Sherlock M, Chan AKC, Zachos M | 2022 | Blood Coagul Fibrinolysis | View Venous thromboembolism in pediatric inflammatory bowel disease: an 11-year population-based nested case-control study in Canada | Researchers | Clinical research |
Verotoxin A subunit protects lymphocytes and T cell lines against X4 HIV infection in vitro | Shi PL, Binnington B, Sakac D, Katsman Y, Ramkumar S, Gariepy J, Kim M, Branch DR, Lingwood C | 2012 | Toxins (Basel) | View Verotoxin A subunit protects lymphocytes and T cell lines against X4 HIV infection in vitro | Researchers | Basic research |
Vers une nouvelle politique de don de sang? Un projet d’Héma-Québec auprès des hommes gais sexuellement actifs fait l’objet d’une étude. | Caza P | 2020 | Actualités UQAM | View Vers une nouvelle politique de don de sang? Un projet d’Héma-Québec auprès des hommes gais sexuellement actifs fait l’objet d’une étude. | Other | Other |
Viper venoms drive the macrophages and hepatocytes to sequester and clear platelets: novel mechanism and therapeutic strategy for venom-induced thrombocytopenia | Shen C, Liu M, Mackeigan DT, Chen ZY, Chen P, Karakas D, Li J, Norris PAA, Li J, Deng Y, Long C, Lai R, Ni H | 2021 | Arch Toxicol | View Viper venoms drive the macrophages and hepatocytes to sequester and clear platelets: novel mechanism and therapeutic strategy for venom-induced thrombocytopenia | Researchers | Basic research |
Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infection | Veljkovic V, Loiseau PM, Figadere B, Glisic S, Veljkovic N, Perovic VR, Cavanaugh DP, Branch DR | 2015 | F1000Res | View Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infection | Researchers | Basic research |
Virus envelope tissue factor promotes infection in mice | Sutherland MR, Simon AY, Shanina I, Horwitz MS, Ruf W, Pryzdial ELG | 2019 | J Thromb Haemost | View Virus envelope tissue factor promotes infection in mice | Researchers | Basic research |
Virus-Platelet Associations | Pryzdial ELG, Lin BH, Sutherland MR | 2017 | Platelets in Thrombotic and Non-Thrombotic Disorders: Pathophysiology, Pharmacology and Therapeutics: an Update | View Virus-Platelet Associations | Researchers | Basic research |
Vitamin D and kidney transplant outcomes: a protocol for a systematic review and meta-analysis | Hesketh CC, Knoll GA, Molnar AO, Tsampalieros A, Zimmerman DL | 2014 | Syst Rev | View Vitamin D and kidney transplant outcomes: a protocol for a systematic review and meta-analysis | Researchers | Clinical research |
von Willebrand factor propeptide variants lead to impaired storage and ER retention in patient-derived endothelial colony-forming cells | Bowman M, Casey L, Selvam SN, Lima PDA, Rawley O, Hinds M, Tuttle A, Grabell J, Iorio A, Walker I, Lillicrap D, James P | 2022 | J Thromb Haemost | View von Willebrand factor propeptide variants lead to impaired storage and ER retention in patient-derived endothelial colony-forming cells | Researchers | Basic research |
Vox Sanguinis International Forum on Donor Incentives | Zeller MP, Ellingham D, Devine D, Lozano M, Lewis P, Zhiburt E, van der Linde L, Goldman M, Nakamura A, Inoue S, Takikawa M, Nakajima K, Turek P, Rehacek V, Sakashita AM, Kutner JM, Karim FA, Hindawi S, Jayasekara SBA, Merz E-M, Gross S, Woimant G, Djoudi R, Byabazaire KD, Irving DO, Abdrakhmanova S, Khalykova A, Yilmaz S, Oruc NE, Huaynalaya IP, Ramirez LAS, Chuhriiev A | 2020 | Vox Sang | View Vox Sanguinis International Forum on Donor Incentives | Blood operators | Benchmarking and standard setting |
Vox Sanguinis International Forum on Donor Incentives: Summary | Zeller MP, Ellingham D, Devine D, Lozano M, Lewis P, Zhiburt E, van der Linde L, Goldman M, Nakamura A, Inoue S, Takikawa M, Nakajima K, Turek P, Rehacek V, Sakashita AM, Kutner JM, Karim FA, Hindawi S, Jayasekara SBA, Merz EM, Gross S, Woimant G, Djoudi R, Byabazaire KD, Irving DO, Abdrakhmanova S, Khalykova A, Yilmaz S, Oruc NE, Huaynalaya IP, Ramirez LAS, Chuhriiev A | 2020 | Vox Sang | View Vox Sanguinis International Forum on Donor Incentives: Summary | Blood operators | Benchmarking and standard setting |
Vox Sanguinis International Forum on donor notification and counselling strategies for markers of transfusion-transmissible infections | Sharma RR, Lozano M, Fearon M, Bigham M, Djoudi R, Gallian P, Woimant G, Lee C, Leung JNS, Tsoi WC, Marwaha N, Sachdev S, Tadokoro K, Tani Y, Matsukura H, Gbuz So O, Shantseva N, Zhiburt E, Hindawi S, Chay J, Huang T, Teo D, Moleli N, Oyonarte S, Jayasekara SBA, Bokhorst A, van den Burg P, Hewitt P, Bianco C, Kessler D | 2017 | Vox Sang | View Vox Sanguinis International Forum on donor notification and counselling strategies for markers of transfusion-transmissible infections | Researchers | Clinical research |
Vox Sanguinis International Forum on donor notification and counselling strategies for markers of transfusion?transmissible infections: Summary | Sharma R, Lozano M, Fearon M, Bigham M, Djoudi R, Gallian P, Woimant G, Lee C, Leung J, Tsoi W | 2017 | Vox Sang | View Vox Sanguinis International Forum on donor notification and counselling strategies for markers of transfusion?transmissible infections: Summary | Blood operators | New or improved product or process |
Vox Sanguinis International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: Summary | Goldman M, Townsend M, Magnussen K, Lozano M, Nissen-Meyer LS, Lee CK, Leung JN, Takanashi M, McKay J, Kvist M, Robitaille N, Deschênes J, Di Angelantonio E, McMahon A, Roberts D, Maghsudlu M, Castrén J, Tiberghien P, Woimant G, Morel P, Kamel H, Bravo M, Shinhar E, Gendelman V, Raz H, Wendel S, Fachini R, Quee F, van den Hurk K, Wiersum J, Grima K, Speedy J, Bruun M, Dunbar N | 2021 | Vox Sang | View Vox Sanguinis International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: Summary | Health care providers | Benchmarking and standard setting |